Literature DB >> 7682761

Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction.

S T Traweek1, J Liu, H Battifora.   

Abstract

Keratin filament are characteristically present in epithelial cells and tumors, but have also been detected in many normal and neoplastic non-epithelial cell types using immunohistochemical techniques. To investigate the validity of this seemingly aberrant protein expression, we applied the highly sensitive polymerase chain reaction (PCR) technique to study keratin gene expression in a variety of non-epithelial tissues. Total RNA was extracted from nine samples of leiomyosarcoma, four non-Hodgkin's lymphoma, seven normal bone marrows, normal lymph node, normal peripheral blood cells, freshly isolated and cultured endothelial cells, cultured skin fibroblasts, and the myeloid leukemia cell line HL-60. Amplification primers and probes for the three most primitive keratin types (8, 18, and 19) were synthesized using published gene sequences. RNA from the breast carcinoma cell line MCF-7, known to be rich in all three keratins, was used as positive control. Concurrently run actin primers were used to confirm RNA integrity. After an initial cycle with reverse transcriptase, PCR amplification was performed for 30 cycles. Southern blots of the PCR products showed variably intense bands corresponding to keratin 8 and 18 gene products in all samples, offering conclusive evidence of keratin gene expression in cells of both stromal and hematopoietic derivation. However, keratin 19 gene transcription was not nearly so ubiquitous, being detected in normal fibroblasts and endothelial cells, two of four non-Hodgkin's lymphoma and four of nine leiomyosarcoma, but not in normal lymph node, peripheral blood cells, HL-60 cells, or any of the seven normal bone marrows examined. Dilutional experiments showed PCR to be highly sensitive in the detection of keratin 19 gene expression, capable of registering one MCF-7 cell in 10(6) HL-60 cells. These studies show that variable levels of keratin 8 and 18 gene expression may be detected by PCR in a wide variety of non-epithelial tissues, supporting previous immunohistochemical and phylogenetic studies. However, keratin 19 gene expression appears to be more restricted and was not evident in any hematopoietic cells devoid of contaminating stromal elements. These findings suggest a role for PCR in the detection of epithelial micrometastasis in certain sites, particularly bone marrow.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682761      PMCID: PMC1886881     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Cytokeratin expression in smooth muscle and smooth muscle tumours.

Authors:  D C Brown; J M Theaker; P M Banks; K C Gatter; D Y Mason
Journal:  Histopathology       Date:  1987-05       Impact factor: 5.087

2.  The use of antikeratin antibodies in the diagnosis of human neoplasms.

Authors:  R B Nagle; K M McDaniel; V A Clark; C M Payne
Journal:  Am J Clin Pathol       Date:  1983-04       Impact factor: 2.493

3.  Malignant soft tissue neoplasms with the histologic features of renal rhabdoid tumors: an ultrastructural and immunohistochemical study.

Authors:  M Tsuneyoshi; Y Daimaru; H Hashimoto; M Enjoji
Journal:  Hum Pathol       Date:  1985-12       Impact factor: 3.466

4.  Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential.

Authors:  M J Hendrix; E A Seftor; Y W Chu; R E Seftor; R B Nagle; K M McDaniel; S P Leong; K H Yohem; A M Leibovitz; F L Meyskens
Journal:  J Natl Cancer Inst       Date:  1992-02-05       Impact factor: 13.506

5.  Comparison of mouse and human keratin 18: a component of intermediate filaments expressed prior to implantation.

Authors:  R G Oshima; J L Millán; G Ceceña
Journal:  Differentiation       Date:  1986       Impact factor: 3.880

6.  Immunocytochemical analysis of Ewing's tumors. Patterns of expression of intermediate filaments and desmosomal proteins indicate cell type heterogeneity and pluripotential differentiation.

Authors:  R Moll; I Lee; V E Gould; R Berndt; A Roessner; W W Franke
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

7.  Keratin in epithelioid sarcoma. An immunohistochemical study.

Authors:  D R Chase; F M Enzinger; S W Weiss; J M Langloss
Journal:  Am J Surg Pathol       Date:  1984-06       Impact factor: 6.394

8.  Synovial sarcoma--a misnomer.

Authors:  M Miettinen; I Virtanen
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

9.  IgD myeloma/immunoblastic lymphoma cells expressing cytokeratin.

Authors:  H F Sewell; W D Thompson; D J King
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

10.  Intermediate-sized filaments of human endothelial cells.

Authors:  W W Franke; E Schmid; M Osborn; K Weber
Journal:  J Cell Biol       Date:  1979-06       Impact factor: 10.539

View more
  42 in total

1.  Detection of circulating epithelial cells after surgery for benign breast disease.

Authors:  D Crisan; D S Ruark; D A Decker; A M Drevon; R G Dicarlo
Journal:  Mol Diagn       Date:  2000-03

2.  Bromodeoxyuridine increases keratin 19 protein expression at a posttranscriptional level in two human lung tumor cell lines.

Authors:  P Meleady; M Clynes
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

3.  Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features.

Authors:  K Suda; B Rothen-Rutishauser; M Günthert; H Wunderli-Allenspach
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

4.  Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival.

Authors:  Chun-Dong Gu; Toshihiro Osaki; Tsunehiro Oyama; Masaaki Inoue; Mantaro Kodate; Kazuhito Dobashi; Takeshi Oka; Kosei Yasumoto
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

5.  Common acute lymphoblastic leukaemia-lymphoma expressing cytokeratin: a case report.

Authors:  F Menestrina; M Lestani; A Scarpa; G Viale; F Bonetti; G Pizzolo; M Chilosi
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  Development and characterization of new immortalized human breast cell lines

Authors: 
Journal:  Cytotechnology       Date:  1998       Impact factor: 2.058

7.  Micrometastases: are they clinically significant disease?

Authors:  H J Andreyev; D Cunningham
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

8.  Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction.

Authors:  S Jonas; S Windeatt; A O-Boateng; C Fordy; T G Allen-Mersh
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

9.  Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.

Authors:  C Milsmann; L Füzesi; E Heinmöller; P Krause; C Werner; H Becker; O Horstmann
Journal:  Langenbecks Arch Surg       Date:  2007-09-18       Impact factor: 3.445

10.  Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies.

Authors:  Dalibor Antolovic; Luis Galindo; Anina Carstens; Nuh Rahbari; Markus W Büchler; Jürgen Weitz; Moritz Koch
Journal:  BMC Biotechnol       Date:  2010-04-28       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.